SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

H.C. Wainwright Earlier Maintained Neutral on Nektar Therapeutics, Raised Price Target to $32

H.C. Wainwright earlier maintained Nektar Therapeutics (NASDAQ:NKTR) with a Neutral and raised the price target from $24 to $32.

Benzinga · -

H.C. Wainwright earlier maintained Nektar Therapeutics (NASDAQ:NKTR) with a Neutral and raised the price target from $24 to $32.